Organogenesis appoints Michael J. Driscoll to board as independent director

Organogenesis Holdings Inc.

Dr. Driscoll appointed independent director effective Feb 15, 2022, expanding board to nine members.
He will serve on audit and nominating committees; receives $72,500 annual retainer.
Received an award of 20,547 RSUs vesting Feb 15, 2023.
Driscoll brings 28 years in financial services and 10 years in academia.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Michael J. Driscoll

Independent Director

ORGO · Organogenesis Holdings Inc.

Effective: 2022-02-15
Filed: February 18, 2022, 6:59 PM ET

On February 17, 2022, the Company announced that Michael J. Driscoll, Ed.D. had been appointed by the board of directors to serve as an independent director of the Company effective as of February 15, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Michael J. Driscoll was appointed as Independent Director at Organogenesis Holdings Inc..

Action: appointed
Role: Independent Director

Exact text from the filing

On February 17, 2022, the Company announced that Michael J. Driscoll, Ed.D. had been appointed by the board of directors to serve as an independent director of the Company effective as of February 15, 2022.

View on SEC.gov

Organogenesis Holdings Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-046638

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.